A Phase III Study of Conventional Radiation Therapy Plus Thalidomide Versus Conventional Radiation Therapy for Multiple Brain Metastases (RTOG 0118) Academic Article uri icon

Overview

MeSH Major

  • Angiogenesis Inhibitors
  • Brain Neoplasms
  • Cranial Irradiation
  • Thalidomide

abstract

  • Thalidomide provided no survival benefit for patients with multiple, large, or midbrain metastases when combined with WBRT; nearly half the patients discontinued thalidomide due to side effects.

publication date

  • May 2008

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1016/j.ijrobp.2007.09.016

PubMed ID

  • 18164847

Additional Document Info

start page

  • 79

end page

  • 86

volume

  • 71

number

  • 1